TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06082635 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06082635
- Sponsor
- Shenzhen TargetRx Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-14
- Primary completion
- 2026-04-30
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.